Dominic Piscitelli - Dec 15, 2022 Form 4/A - Amendment Insider Report for Oric Pharmaceuticals, Inc. (ORIC)

Role
Chief Financial Officer
Signature
/s/ Christian Kuhlen, attorney-in-fact
Stock symbol
ORIC
Transactions as of
Dec 15, 2022
Transactions value $
-$6,854
Form type
4/A - Amendment
Date filed
2/17/2023, 03:23 PM
Date Of Original Report
Dec 16, 2022
Previous filing
Jul 21, 2022
Next filing
Feb 2, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORIC Common Stock Sale -$6.85K -2.23K -3.2% $3.08 67.3K Dec 15, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is filed to correct the number of shares sold, and the price per share at which the shares were sold, to cover the tax withholding obligations in connection with the vesting of RSUs reported in the Form 4 filed December 16, 2022 and does not represent a discretionary sale by the Reporting Person.